TrialHaematologica2023

Molecular targeting of the UDP-glucuronosyltransferase enzymes in high-eukaryotic translation initiation factor 4E refractory/relapsed acute myeloid leukemia patients: a randomized phase II trial of vismodegib, ribavirin with or without decitabine.

Sarit Assouline et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.